1. A pharmaceutical composition containing at least 20 (wt.)% Milk fat globules (MFG) and at least one C-fatty acid and not containing zinc oxide for the treatment of skin diseases and / or disorders associated with abnormal cell proliferation. 2 . A composition according to claim 1, characterized in that the amount of MFG is from 20 to 40 (wt.)%. 3. A composition according to claim 1 or 2, characterized in that the amount of MFG is from 20 to 25 (wt.)%. 4. A composition according to claim 1, characterized in that the size of the MFG is in the range from 1 to 10 μm. A composition according to claim 1, characterized in that said C-Fatty acid is selected from the group consisting of stearic acid, oleic acid, isostearic acid, linoleic acid, cetearyl acid, myristic acid. A composition according to claim 1, characterized in that the amount of C-Fatty acid is 10 (wt.)%. 7. A composition according to claim 1, characterized in that said composition further comprises an emulsifier and is an oil-in-water type MFG emulsion, wherein MFG are the active ingredient. A composition according to claim 1, characterized in that the composition can be administered topically, intravenously, intramuscularly or orally. The composition according to claim 1, characterized in that the skin diseases are selected from skin wounds and skin burns, skin scars, keloid scars and hyperkeratinization, and disorders associated with abnormal cell proliferation are selected from squamous cell carcinoma or malignant neoplasm. The composition of claim 9, wherein skin wounds and / or skin burns are infected with pseudomonas aeruginosa. 11. A method of obtaining a pharmaceutical composition according to PP. 1-7, comprising the step of melting the emulsifier in boiling water, the step of melting the fatty material containing MFG and fatty acids, and the mixing step1. Фармацевтическая композиция, содержащая не менее 20 (вес.)% молочных жирных глобул (MFG) и не менее одной С-Сжирной кислоты и не содержащая окси
